Central Nervous System Leukemia — Clinical Trials

MONDO:00016063 active·2 recruitingLast updated: Mar 19, 2026, 2:04 AM

Trial Landscape

Central Nervous System Leukemia has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment3

Procedure2

Biological Therapy2

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 2

Phase 3

Sponsor Types

NIH1Academic/Other1Collaborative Network1

Trial Locations

United States3 trials

Australia2 trials

Canada2 trials

New Zealand2 trials

Puerto Rico2 trials

Ireland1 trial

Switzerland1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 3Recruiting

NCT03959085

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Sponsor:Children's Oncology Group

United StatesStarted: Oct 2019Est. completion: Mar 2032Updated: Mar 2026

Phase 2Recruiting

NCT05735717

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Sponsor:Masonic Cancer Center, University of Minnesota

United StatesStarted: May 2023Est. completion: Nov 2030Updated: Jul 2025

Phase 3Active, Not Recruiting

NCT02883049

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Feb 2012Est. completion: Oct 2026Updated: Nov 2025

Stay informed about clinical trials for Central Nervous System Leukemia.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 2:04 AM